Managing Heart Disease in Persons with Diabetes

Deborah L McCrea1

  • 1Department of Graduate Studies, UTHealth Houston, Cizik School of Nursing, 6901 Bertner, Suite 695, Houston, TX 77030, USA.

Insights

Diabetes mellitus affects 38 million Americans, increasing cardiovascular disease risk. This article reviews the latest guidelines for reducing cardiovascular risk in individuals with diabetes.

Area of Science:

  • Endocrinology
  • Cardiology
  • Metabolic Disorders

Background:

  • Diabetes mellitus impacts 38 million US individuals, diagnosed and undiagnosed.
  • Chronic complications stem from insulin issues and metabolic dysregulation, leading to hyperglycemia and dyslipidemia.
  • Individuals with diabetes face a 2-8 fold increased risk of cardiovascular disease (CVD), including heart disease, stroke, and heart failure.

Purpose of the Study:

  • To discuss the most recent cardiovascular risk reduction guidelines for patients with diabetes.
  • To inform healthcare providers about updated strategies for managing CVD risk in diabetic populations.

Main Methods:

  • Review of current clinical practice guidelines for diabetes management.
  • Analysis of evidence supporting recent cardiovascular risk reduction recommendations.
  • Synthesis of guideline recommendations for practical application.

Main Results:

  • Persistent hyperglycemia, dyslipidemia, and metabolic disorders are key drivers of complications.
  • Cardiovascular disease accounts for over 50% of deaths in type 2 diabetes patients.
  • Guidelines emphasize comprehensive risk factor management.

Conclusions:

  • Effective management of diabetes and its associated metabolic pathways is crucial for reducing cardiovascular morbidity and mortality.
  • Adherence to the latest cardiovascular risk reduction guidelines is essential for improving outcomes in individuals with diabetes.
  • Ongoing research and guideline updates are vital for optimizing patient care.

Related Concept Videos

Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
232
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.4K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.1K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
499
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
852
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
10.7K